IDEX Biometrics Announces Successful Share Capital Increase
IDEX Biometrics ASA has made significant strides in enhancing its share capital through the completion of its Tranche 2 shares. This milestone follows the company's earlier announcement regarding a dual-tranche private placement that raised gross proceeds of NOK 70 million.
Details of the Share Capital Increase
The share capital increase pertaining to the Tranche 2 shares has officially been registered. Shareholders can expect these shares to be delivered shortly. However, it’s essential to note that the shares will be issued under a separate and non-tradable International Securities Identification Number (ISIN) until IDEX Biometrics releases a prospectus sanctioned by the Norwegian Financial Supervisory Authority.
Current Share Capital Structure
Post-issue, IDEX Biometrics will have a share capital of NOK 120,812,483.10, which will be divided into 805,416,554 shares, each bearing a nominal value of NOK 0.15. This substantial capital structure positions IDEX for future opportunities within the biometric technology market.
About IDEX Biometrics and Its Offerings
IDEX Biometrics ASA is recognized as a global authority in fingerprint biometrics, providing advanced authentication solutions for various applications including payment systems, access control, and digital identity verification. Their technologies are designed to enhance convenience and security while delivering exceptional user experiences.
Partnerships and Innovations
The organization utilizes patented and proprietary sensor technologies alongside integrated circuit designs and software to cater to card-based applications specifically tailored for payment and digital authentication processes. By collaborating closely with leading card manufacturers and tech firms, IDEX Biometrics delivers cutting-edge solutions that meet the evolving demands of the market.
Contact Information for Investor Enquiries
For those seeking further insights or clarifications, Marianne Bøe, the Investor Relations representative, is available for contact via telephone at +47 918 00186 or through email at marianne.boe@idexbiometrics.com.
Frequently Asked Questions
What is the significance of the share capital increase?
The share capital increase allows IDEX Biometrics to bolster its financial foundation, enabling it to invest in research and development and enhance its product offerings.
How will the new shares affect existing shareholders?
The delivery of new shares expands the total share count but is intended to strengthen the company’s capital and support growth initiatives, which can ultimately benefit existing shareholders.
Can the Tranche 2 shares be traded immediately?
No, the Tranche 2 shares will be issued under a separate ISIN and cannot be traded until a prospectus is published by the company.
What technologies does IDEX specialize in?
IDEX specializes in fingerprint biometrics, focusing on developing authentication solutions that span payments, access control, and digital identity verification.
Who can I contact for further information?
Investors can reach out to Marianne Bøe in Investor Relations for questions regarding the share capital increase or about the company’s operations.
